Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 188 of 1,261
  1. US 11679101

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  2. US 11680105

    Antibody fragments for detecting cancer and methods of use

    Regents of the University of Minnesota · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  3. US 11679100

    Methods of enhancing immunity

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  4. US 11680034

    Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

    PTC THERAPEUTICS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  5. US 11680036

    Methods for making and using endoxifen

    ATOSSA THERAPEUTICS, INC. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  6. US 11679151

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  7. US 11679093

    2-naphthimidamides, analogues thereof, and methods of treatment using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  8. US 11679121

    Morpholino oligonucleotides useful in cancer treatment

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  9. US 11679130

    Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    CRISPR THERAPEUTICS AG · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  10. US 11679075

    Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  11. US 11672785

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  12. US 11672813

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  13. US 11672872

    Anti-transferrin receptor antibody and uses thereof

    Dyne Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  14. US 11672831

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Takeda Pharmaceutical Company Limited · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  15. US 11673930

    IL10 agonists and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  16. US 11672789

    Radiation mitigator and method of use thereof

    The Board of Regents of the University of Oklahoma · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  17. US 11672876

    Imageable embolic microsphere

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  18. US 11673893

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  19. US 11673879

    Substituted pyrimidines and methods of use

    Theravance Biopharma R&D IP, LLC · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  20. US 11672868

    Bicyclic peptide ligands specific for MT1-MMP

    BicycleRD Limited · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  21. US 11672774

    Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  22. US 11673866

    Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

    The Regents of the University of California · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  23. US 11673860

    Crystalline siponimod fumaric acid and polymorphs thereof

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  24. US 11673887

    N-acyl amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.